Super League Enterprise(SLE)

Search documents
Super League Announces Second Quarter 2024 Financial Results
GlobeNewswire News Room· 2024-08-14 20:51
~ Q2 2024 Highlighted by Launch of Innovative Scalable Products, SOUNDZ and Unlockables, New Dedicated Worlds and a Strategic Partnership with Meta-Stadiums~ ~ Net Loss Improvement in Q2 2024 Attributable to Reduced Spend Paves the Way for First Profitable Quarter in Q4 ~ SANTA MONICA, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE), a leader in redefining the gaming industry as a media channel, has released its second quarter 2024 financial results in the form of a shareholder letter w ...
Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024
GlobeNewswire News Room· 2024-08-01 12:00
SANTA MONICA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the "Company"), a leader in redefining the gaming industry as a media channel, announced today that the Company will post its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link. | --- | --- | |------------------------|----------------- ...
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
GlobeNewswire News Room· 2024-07-02 10:31
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company"), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient has been dosed in its Phase 2 open-label clinical trial evaluating Descartes-08 in patients with systematic lupus erythematosus (SLE). Descartes-08, Cartesian's lead mRNA cell therapy candidate and a potential first-in-class mRNA-engineered chimeric antigen receptor ...
Bebe Rexha Returns to Roblox with New Listening Party Through Super League's Innovative Scalable Music Offering - SOUNDZ
Newsfilter· 2024-06-28 12:05
SOUNDZ By Bebe Rexha launches on June 28, 2024, with Bebe Rexha being brought to life through a custombuilt avatar set to dance and engage with Bebe Rexha's fans and music lovers. Fans will be able to dance together, play rhythm-based games, try on and purchase Bebe Rexha virtual merch, and earn special inexperience status within Carry A Friend!, Paradise RP, and The Floor Is Lava. Fans can also access Super League's rewards and loyalty platform and enter to win a personal video message from Bebe on Communi ...
Super League Issues Mid-Year Update, Expects Record 2024 Revenues
GlobeNewswire News Room· 2024-06-21 12:00
Fellow Shareholders, The opportunity in front of us remains enticing with strong secular industry tailwinds driving growth in these lucrative 3D worlds where an impressive 500 million people play, shop and socialize. As we grow, we're finding powerful new applications for digital experiential campaigns in areas such as cost-efficient research and development at scale with real-time feedback for test products, or even human resources where our products and technology can deliver results that redefine the tra ...
Super League Issues Mid-Year Update, Expects Record 2024 Revenues
Newsfilter· 2024-06-21 12:00
SANTA MONICA, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the "Company"), a leading creator and publisher of content experiences and media solutions across the world's largest immersive platforms, today issued a mid-year update from the Company's Chief Executive Office, Ann Hand. As we approach the halfway mark of the year, I wanted to provide a business update around some of the positive momentum we've continued to generate. Super League's size and duration of programs continue to ...
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201
GlobeNewswire News Room· 2024-06-14 06:00
– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May 28, 2024 – – Improvements in both patients' specific disease measures, consistent with academic experience of a similar 4- 1BB CD19-CAR T, suggest emerging clinical benefit with CABA-201 while discontinuing all disease-specific therapies other than a planned steroid taper in one patient – – 18 sites open and recruiting across four Phase 1/2 RESET™ trials with 5 patients enrolled as ...
Super League CEO Ann Hand to Participate in H.C. Wainwright Virtual Fireside Chat
Newsfilter· 2024-06-05 12:00
~ Discussion to Explore SLE's Leading 3D Web Solutions and Brand Engagement in Immersive World Advertising ~ SANTA MONICA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Super League (NASDAQ:SLE) (the "Company"), a leading creator and publisher of content experiences and media solutions across the world's largest immersive platforms, today announced participation in a virtual fireside chat hosted by the Company's research analyst Scott Buck of H.C. Wainwright on Tuesday, June 11, 2024, at 1:00pm ET. During the f ...
Super League CEO, Ann Hand, to Participate in Maxim Group Virtual Fireside Chat on the Marketing Channel of the Future, Leading Global Brands into 3D Immersive Platforms
Newsfilter· 2024-05-30 12:00
Core Insights - Super League (NASDAQ:SLE) will participate in a virtual fireside chat on June 5, 2024, hosted by Maxim Group [1][2] - The discussion will focus on the growing interest from global brands in Super League's media solutions and their 3D engagement strategies [2] Company Overview - Super League is a leading creator and publisher of content experiences and media solutions across major immersive platforms like Roblox, Minecraft, and Fortnite Creative [3] - The company serves as an end-to-end activation partner for global brands, offering a comprehensive range of development, distribution, monetization, and optimization capabilities [3] - Super League aims to engage users through dynamic programs and accelerates intellectual property and audience success in the rapidly growing media sector [3]
GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
globenewswire.com· 2024-05-21 12:35
Data presented at the 14th International Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV® (nintedanib), a leading tyrosine kinase inhibitor with 2025 projected sales of $5 billion1 Company targeting IND filing for GRI-0803 in Q3 2024 with topline data expected Q4 2024 GRI Bio's second asset in development, GRI-0803, is a novel activator of human type 2 NKT cells. Activation of type 2 NKT leads to a dendritic cell-mediated inhibition of type 1 invariant NKT (iNKT) cell ...